Blood Transfusion Guidelines

Primary Transfusion Thresholds

The American College of Cardiology recommends transfusing at hemoglobin <8 g/dL in patients with preexisting coronary artery disease, acute coronary syndrome, or congestive heart failure 1, 5
The American Society of Anesthesiologists suggests transfusing at hemoglobin <7 g/dL in hemodynamically stable hospitalized patients without cardiovascular disease 1, 3
A restrictive strategy (7-8 g/dL) reduces transfusion exposure by approximately 40% without increasing mortality, morbidity, or adverse outcomes 2

The American College of Critical Care Medicine states that hemoglobin level alone should not be used as a transfusion trigger, and the decision must incorporate clinical signs of inadequate oxygen delivery and hemodynamic status 4, 2
Biochemical markers of tissue hypoxia, such as elevated lactate, low mixed venous oxygen saturation (SvO2), and metabolic acidosis, should be considered when assessing the need for transfusion 1, 2

The National Comprehensive Cancer Network recommends administering one unit of packed RBCs at a time, then reassessing clinical status and hemoglobin before giving additional units 7, 1, 2
The target hemoglobin post-transfusion should be 7-9 g/dL in most patients, with higher targets having no additional benefit 3, 2

The American College of Cardiology advises against attempting to normalize blood pressure during uncontrolled hemorrhage, and instead recommends permissive hypotension until definitive hemorrhage control 3
The American College of Surgeons recommends combining local hemostatic measures with volume resuscitation using isotonic crystalloids (0.9% NaCl or Ringer's lactate) 5

The American College of Cardiology recommends transfusing at hemoglobin <7 g/dL in resuscitated trauma patients 2
The National Comprehensive Cancer Network suggests transfusing at hemoglobin <7 g/dL in cancer patients, unless symptomatic at higher levels 7

The American College of Cardiology warns that liberal transfusion strategies (targeting hemoglobin >10 g/dL) increase complications, including venous thromboembolism, arterial thromboembolism, and mortality, without providing benefit 7, 2
The American Society of Anesthesiologists notes that transfusion-related acute lung injury (TRALI) is a leading cause of transfusion-associated mortality 2